The detection of a MyD88 mutation is a key indicator for diagnosing B-cell lymphomas, including primary vitreoretinal lymphoma (PVRL), central nervous system diffuse large B-cell lymphoma (CNS DLBCL), or other forms of B-cell lymphoma [12]. This evidence concerns the gene MYD88 and diffuse large B-cell lymphoma of the central nervous system.